In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
We received an updated WNV package insert; please note the manufacturer and license number has been ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
The new online Learning Center with new content can still be found under the “Training” folder on ...